MedTrace Logo

Pericoronary Fat Attenuation Index and High-risk Plaque in Patients With Acute Coronary Syndrome

NCT04792047 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2021-03-10

No results posted yet for this study

Summary

This study aimed to investigate the relationship between CCTA-based pericoronary inflammation and plaque features as well as local immune-inflammatory biomarkers in ACS patients. It is hypothesized that perivascular FAI might serve as a reliable sensor of coronary immune-inflammatory disorder, and closely related to the plaque vulnerability.

Conditions

  • Acute Coronary Syndrome

Interventions

DIAGNOSTIC_TEST

HRP frequency, plaque compostion and local immune-inflammatory activation

HRP frequency, plaque compostion were detected by CCTA method. Local T cell subsets and their intracellular cytokines levels were detected by Flow Cytometry.

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Song Ding · RenJi Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-01-31
Completion
2020-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04792047 on ClinicalTrials.gov